Lates News

In early trading on Monday, the stock price of Israeli clinical medical diagnostics company Check-Cap soared 233.8% after its merger agreement with MBody AI. According to the agreement, MBody AI will hold 90% of the shares of the merged entity, while Check-Cap will retain 10% of the shares. Both parties aim to enter the high-growth artificial intelligence industry.